covid fda - Search News

Order byBest matchMost fresh

FDA, Covid-19

Digest more

Top News

Overview

Impacts

FDA to limit future Covid-19 shots to older people and those at risk of serious infection

Millions of healthy adults and kids will likely lose access to updated vaccines under the new criteria.

· 14h · on MSN

MedPage Today · 3h

FDA Officials Detail Plan to Limit COVID Shots

· 13h · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

· 11h

· 14h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 14h

US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved

FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 10h

· 7h

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 7h

F.D.A. Poised to Restrict Access to Covid Vaccines

3hon MSN

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

5hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

1don MSN

FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.